MUSC researchers used machine learning on fMRI scans to predict which smokers would benefit from repetitive transcranial magnetic stimulation (rTMS) for quitting smoking.
Key Details
- 1MUSC study combines machine learning and fMRI to personalize rTMS for smoking cessation.
- 242 participants took part in an earlier study, split into real vs sham TMS groups.
- 3The salience network's connectivity in the brain, analyzed by AI, correlated best with positive rTMS outcomes.
- 4Machine learning enabled predictions of individual responsiveness to rTMS based on brain network analysis.
- 5Study published in Brain Connectivity; NIH grant support cited.
- 6The research establishes groundwork for precision neuromodulation and larger future trials.
Why It Matters
This study demonstrates how imaging AI can enhance precision medicine by analyzing fMRI scans to tailor neuromodulation therapies. The approach could extend to other substance use disorders, highlighting a broader potential impact for radiology-based AI tools.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.